A brain stroke occurs when the blood supply to a part of the brain is disrupted, leading to the loss of brain function.

This disruption can be due to either ischemia (insufficient blood flow) or hemorrhage (bleeding). 

When an area of the brain doesn't receive enough blood or is damaged by bleeding, it cannot function normally. 

This can result in various impairments, such as motor deficits affecting one or more limbs on one side of the body, difficulties with speech comprehension or articulation (aphasia), or vision impairments affecting one side of the visual field.

Ischemic strokes, the most common type, are caused by blockages in blood vessels, either from a blood clot (thrombosis), a traveling clot (arterial embolism), or reduced blood flow to the brain (cerebral hypoperfusion). 

Hemorrhagic strokes, conversely, are caused by the rupture of blood vessels in the brain, leading to bleeding directly into the brain tissue or into the fluid-filled space surrounding the brain (subarachnoid space). 

A stroke is a medical emergency demanding immediate attention, as it can cause permanent neurological damage or even death. 

Acute treatment for an ischemic stroke sometimes involves thrombolysis (often called "clot busters") administered in a hospital setting, while some hemorrhagic strokes may benefit from neurosurgery.

The process of recovering lost functions after a stroke is known as stroke rehabilitation. 

Ideally, this specialized rehabilitation takes place in a dedicated stroke unit and involves a multidisciplinary team of health professionals, including speech and language therapists, physical therapists, and occupational therapists.

Rehabilitation should begin as soon as possible after a stroke and can last anywhere from a few days to over a year. 

While most functional recovery typically occurs within the first few months (often referred to as a "window of opportunity," sometimes considered to close after six months by some rehabilitation units), it's important to note that patients have been known to continue improving for years.

Aphasia Improvement: A recent sham-controlled study investigated the effectiveness of BrainsWay's Deep TMS H-coil over the right inferior frontal gyrus in Post-Stroke patients suffering from aphasia (difficulty with speech). 

The results provided evidence that high-frequency Deep TMS in this area can improve naming performance in patients with chronic Post-Stroke aphasic deficits.

Lower Limb Motor Function: Another sham-controlled study explored the feasibility of BrainsWay's Deep TMS H-coil treatment over the motor cortex for stroke patients experiencing deficiencies in lower limb motor functions. 

This study found that real Deep TMS, as opposed to sham treatment, was associated with a significant improvement in lower limb Fugl-Meyer scores (p<0.001) and the 10-meter walk test (p=0.05).

This positive effect not only persisted but even increased over a four-week follow-up period. 

A significant increase in walking speed during the 10-meter walk test (p=0.04) was also observed after real Deep TMS compared to sham treatment.

You are viewing a page that is not intended for persons in the United States, and includes information about treatment applications that HAVE NOT BEEN CLEARED by the FDA for safety and efficacy.

However, BrainsWay Deep TMS™ has received the European CE Mark for the treatment of many conditions.

This significant approval underscores the therapy's established safety and efficacy for these indications in Europe. While regulatory statuses vary by region, this CE Mark highlights the recognized potential of Deep TMS as a therapeutic option for:

Major Depressive Disorder (MDD)

Anxiety Depression

Obsessive-Compulsive Disorder (OCD)

Smoking Cessation

Alzheimer's Disease (AD)

Autism

Bipolar Disorder

Chronic Pain

Multiple Sclerosis (MS)

Parkinson's Disease

Post-Stroke Rehabilitation

Post-Traumatic Stress Disorder (PTSD)

Negative Symptoms of Schizophrenia